185 related articles for article (PubMed ID: 38220426)
1. In silico network pharmacology study on Glycyrrhiza glabra: Analyzing the immune-boosting phytochemical properties of Siddha medicinal plant against COVID-19.
Sekaran K; Karthik A; Varghese RP; Sathiyarajeswaran P; Shree Devi MS; Siva R; George Priya Doss C
Adv Protein Chem Struct Biol; 2024; 138():233-255. PubMed ID: 38220426
[TBL] [Abstract][Full Text] [Related]
2. Glossary of phytoconstituents: Can these be repurposed against SARS CoV-2? A quick in silico screening of various phytoconstituents from plant Glycyrrhiza glabra with SARS CoV-2 main protease.
Hejazi II; Beg MA; Imam MA; Athar F; Islam A
Food Chem Toxicol; 2021 Apr; 150():112057. PubMed ID: 33592201
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Malekmohammad K; Rafieian-Kopaei M
Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
[TBL] [Abstract][Full Text] [Related]
4. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
5. Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.
Idrees M; Khan S; Memon NH; Zhang Z
Curr Pharm Biotechnol; 2021; 22(4):444-450. PubMed ID: 32619167
[TBL] [Abstract][Full Text] [Related]
6. Chemical composition and pharmacological mechanism of ephedra-glycyrrhiza drug pair against coronavirus disease 2019 (COVID-19).
Li X; Qiu Q; Li M; Lin H; Cao S; Wang Q; Chen Z; Jiang W; Zhang W; Huang Y; Luo H; Luo L
Aging (Albany NY); 2021 Feb; 13(4):4811-4830. PubMed ID: 33581688
[TBL] [Abstract][Full Text] [Related]
7. The Efficacy of Traditional Medicinal Plants in Modulating the Main Protease of SARS-CoV-2 and Cytokine Storm.
Choe J; Har Yong P; Xiang Ng Z
Chem Biodivers; 2022 Nov; 19(11):e202200655. PubMed ID: 36125969
[TBL] [Abstract][Full Text] [Related]
8. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies.
Azeem M; Mustafa G; Mahrosh HS
Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514
[TBL] [Abstract][Full Text] [Related]
9. Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review.
Pastorino G; Cornara L; Soares S; Rodrigues F; Oliveira MBPP
Phytother Res; 2018 Dec; 32(12):2323-2339. PubMed ID: 30117204
[TBL] [Abstract][Full Text] [Related]
10.
Zhurinov MZ; Miftakhova AF; Keyer V; Shulgau ZT; Solodova EV; Kalykberdiyev MK; Abilmagzhanov AZ; Talgatov ET; Ait S; Shustov AV
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630394
[TBL] [Abstract][Full Text] [Related]
11. In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2.
Mousavi SS; Karami A; Haghighi TM; Tumilaar SG; Fatimawali ; Idroes R; Mahmud S; Celik I; Ağagündüz D; Tallei TE; Emran TB; Capasso R
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577194
[TBL] [Abstract][Full Text] [Related]
12. Polypharmacology of some medicinal plant metabolites against SARS-CoV-2 and host targets: Molecular dynamics evaluation of NSP9 RNA binding protein.
Bandyopadhyay S; Abiodun OA; Ogboo BC; Kola-Mustapha AT; Attah EI; Edemhanria L; Kumari A; Jaganathan R; Adelakun NS
J Biomol Struct Dyn; 2022; 40(22):11467-11483. PubMed ID: 34370622
[TBL] [Abstract][Full Text] [Related]
13. In Silico Identification of Potential Natural Product Inhibitors of Human Proteases Key to SARS-CoV-2 Infection.
Vivek-Ananth RP; Rana A; Rajan N; Biswal HS; Samal A
Molecules; 2020 Aug; 25(17):. PubMed ID: 32842606
[TBL] [Abstract][Full Text] [Related]
14. Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host.
Agrawal S; Pathak E; Mishra R; Mishra V; Parveen A; Mishra SK; Byadgi PS; Dubey SK; Chaudhary AK; Singh V; Chaurasia RN; Atri N
Comput Biol Med; 2022 Oct; 149():106049. PubMed ID: 36103744
[TBL] [Abstract][Full Text] [Related]
15. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19.
Vardhan S; Sahoo SK
Comput Biol Med; 2020 Sep; 124():103936. PubMed ID: 32738628
[TBL] [Abstract][Full Text] [Related]
16. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
[TBL] [Abstract][Full Text] [Related]
17. Cameroonian medicinal plants as potential candidates of SARS-CoV-2 inhibitors.
Fouedjou RT; Chtita S; Bakhouch M; Belaidi S; Ouassaf M; Djoumbissie LA; Tapondjou LA; Abul Qais F
J Biomol Struct Dyn; 2022; 40(19):8615-8629. PubMed ID: 33908318
[TBL] [Abstract][Full Text] [Related]
18. Traditional Uses, Bioactive Chemical Constituents, and Pharmacological and Toxicological Activities of
El-Saber Batiha G; Magdy Beshbishy A; El-Mleeh A; Abdel-Daim MM; Prasad Devkota H
Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32106571
[TBL] [Abstract][Full Text] [Related]
19. Potential Leads from Liquorice Against SARS-CoV-2 Main Protease using Molecular Docking Simulation Studies.
Sinha SK; Prasad SK; Islam MA; Chaudhary SK; Singh S; Shakya A
Comb Chem High Throughput Screen; 2021; 24(4):591-597. PubMed ID: 32807047
[TBL] [Abstract][Full Text] [Related]
20. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.
Abdizadeh R; Hadizadeh F; Abdizadeh T
Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
